The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1045
ISSUE 1045
January 29, 1999
Issue 1045
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Celecoxib for Arthritis
January 29, 1999 (Issue: 1045)
Celecoxib, a selective COX-2 inhibitor, has been approved by the FDA for treatment of osteoarthritis and rheumatoid arthritis.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.